In Brief: American Biogenetic Sciences
This article was originally published in The Gray Sheet
Executive Summary
American Biogenetic Sciences: Enters worldwide license and collaboration agreement with Roche under which the firms will develop ABS' TpP solfib soluble fibrin test, which is used to detect active thrombosis, in a "latex based particle agglutination format" for use in Roche's Cobas automated diagnostic systems. Under the deal, ABS will manufacture the TpP test for Roche in return for a "percentage of Roche's net selling price plus a royalty on sales made by Roche," ABS reports. The two firms also will share profits from sales of the test to other diagnostic companies that utilize similar particle agglutination technology...